Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus

Marva M. Moxey-Mims; Karen Preston; Barbara Fivush; Fredrick McCurdy

doi:10.1007/BF00858834

Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus

Marva M. Moxey-Mims, Karen Preston, Barbara Fivush, Fredrick McCurdy

School of Medicine

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Twenty-three pediatric dialysis patients 16 hemodialysis (HD) and 17 peritoneal dialysis (PD)], with a mean age of 13.9 years, were vaccinated against hepatitis B virus and their seroconversion rates were analyzed. There was no significant difference in the mean duration of dialysis between the HD and PD groups, or between responders and nonresponders to the vaccine. In the HD group, there was a response rate of 83.3% while the PD patients had a response rate of 88.2%. The only patients failing to seroconvert after the three vaccine series all had systemic lupus erythematosus and were taking oral corticosteroids.

Original language	English (US)
Pages (from-to)	171-173
Number of pages	3
Journal	Pediatric Nephrology
Volume	4
Issue number	2
DOIs	https://doi.org/10.1007/BF00858834
State	Published - Mar 1 1990

Keywords

Corticosteroids
Hemodialysis
Hepatavax-B
Peritoneal dialysis
Systemic lupus erythematosus

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Nephrology

Access to Document

10.1007/BF00858834

Cite this

@article{56bd3de694b34aedb34fc12b57db17cd,

title = "Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus",

abstract = "Twenty-three pediatric dialysis patients 16 hemodialysis (HD) and 17 peritoneal dialysis (PD)], with a mean age of 13.9 years, were vaccinated against hepatitis B virus and their seroconversion rates were analyzed. There was no significant difference in the mean duration of dialysis between the HD and PD groups, or between responders and nonresponders to the vaccine. In the HD group, there was a response rate of 83.3% while the PD patients had a response rate of 88.2%. The only patients failing to seroconvert after the three vaccine series all had systemic lupus erythematosus and were taking oral corticosteroids.",

keywords = "Corticosteroids, Hemodialysis, Hepatavax-B, Peritoneal dialysis, Systemic lupus erythematosus",

author = "Moxey-Mims, {Marva M.} and Karen Preston and Barbara Fivush and Fredrick McCurdy",

year = "1990",

month = mar,

day = "1",

doi = "10.1007/BF00858834",

language = "English (US)",

volume = "4",

pages = "171--173",

journal = "Pediatric Nephrology",

issn = "0931-041X",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Heptavax-B in pediatric dialysis patients

T2 - effect of systemic lupus erythematosus

AU - Moxey-Mims, Marva M.

AU - Preston, Karen

AU - Fivush, Barbara

AU - McCurdy, Fredrick

PY - 1990/3/1

Y1 - 1990/3/1

N2 - Twenty-three pediatric dialysis patients 16 hemodialysis (HD) and 17 peritoneal dialysis (PD)], with a mean age of 13.9 years, were vaccinated against hepatitis B virus and their seroconversion rates were analyzed. There was no significant difference in the mean duration of dialysis between the HD and PD groups, or between responders and nonresponders to the vaccine. In the HD group, there was a response rate of 83.3% while the PD patients had a response rate of 88.2%. The only patients failing to seroconvert after the three vaccine series all had systemic lupus erythematosus and were taking oral corticosteroids.

AB - Twenty-three pediatric dialysis patients 16 hemodialysis (HD) and 17 peritoneal dialysis (PD)], with a mean age of 13.9 years, were vaccinated against hepatitis B virus and their seroconversion rates were analyzed. There was no significant difference in the mean duration of dialysis between the HD and PD groups, or between responders and nonresponders to the vaccine. In the HD group, there was a response rate of 83.3% while the PD patients had a response rate of 88.2%. The only patients failing to seroconvert after the three vaccine series all had systemic lupus erythematosus and were taking oral corticosteroids.

KW - Corticosteroids

KW - Hemodialysis

KW - Hepatavax-B

KW - Peritoneal dialysis

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=0025281484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025281484&partnerID=8YFLogxK

U2 - 10.1007/BF00858834

DO - 10.1007/BF00858834

M3 - Article

C2 - 2144452

AN - SCOPUS:0025281484

SN - 0931-041X

VL - 4

SP - 171

EP - 173

JO - Pediatric Nephrology

JF - Pediatric Nephrology

IS - 2

ER -

Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this